APOA1 and Hypercholesterolemia: Several lipid-lowering drugs and apoA-I are reportedly effective in improving lymphatic functions, including lymphatic drainage and reverse cholesterol transport; accordingly, it is possible that hypercholesterolemia can precede lymphatic insults, which is presumably mediated through dyslipidemic lipid mediators.